
Featured
Premium
Confidential Source•Oct 28, 2026
LAPROPHAN IPO Guide: Everything Investors Need to Know Before the Casablanca Stock Exchange Debut
Read More
Stay ahead of the market with our curated AI-powered financial news and expert analysis.
Promopharm’s first‑quarter 2026 turnover fell to DH208.2 million, a 1.9 % dip from the same period last year, primarily driven by weaker hospital‑segment sales. Despite the slight decline, the firm kept commercial momentum alive with successful new‑product launches, trimmed its total debt to DH182 m...

Sothema, the Moroccan pharmaceutical company, has formally notified the Competition Council of its planned acquisition of certain pharmaceutical asset...